Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion type Assertion NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_head.
- NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_provenance.
- NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion evidence source_evidence_literature NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_provenance.
- NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion SIO_000772 14607763 NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_provenance.
- NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion wasDerivedFrom befree-20150227 NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_provenance.
- NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_assertion wasGeneratedBy ECO_0000203 NP332084.RAPxfFGkpdtahmsg2Gjg3LTbtenm70NNwyFj__d4mNoBs130_provenance.